ArticleFrontiers in neuroscience2026
Structural changes in gray matter and white matter across the Alzheimer's disease continuum.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The pathophysiological spectrum of Alzheimer's disease (AD) is a continuum, with the AT(N) framework defining stages based on the presence of Aβ pathology, tau pathology, and neurodegeneration. However, the spatial characteristics of gray matter (GM) and white matter (WM) changes at different stages remain insufficiently defined. This study aimed to establish a cross-sectional cohort of the AD continuum using the AT(N) staging system and systematically delineate the spatial features of GM and WM changes across this spectrum. Methods: This study included subjects across the AD continuum with defined AT(N) stages [ Results: A region-specific pattern of GM volume atrophy was observed: hippocampal (HIP) volume atrophy was most pronounced in the A + T- CN subgroup. The parahippocampal gyrus (PHG), amygdala (AMYG), and fusiform gyrus (FFG) showed volume atrophy in the A + T + CN subgroup. In the A + T + MCI and A + T + AD subgroups, extensive GM volume reduction involved global GM regions. For WM alterations, reduced FA values were observed in the hippocampal cingulum (CgH) at the A + T + CN stage. In A + T + MCI and A + T + AD subgroups, a broader scope of WM FA reduction was observed. Correlation analyses revealed that HIP volume was positively associated with CgH FA values and Aβ levels, while both HIP volume and CgH FA values were negatively associated with P-tau levels, and both HIP volume and CgH FA values positively correlated with global cognition and memory performance. Conclusion: GM and WM alterations are widespread in the AD continuum. Early selective GM volume loss and impaired WM axonal integrity are associated with pathological processes in AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.